TABLE OF CONTENTS
CHAPTER 1 PREFACE
1.1 REPORT DESCRIPTION
1.2 RESEARCH METHODOLOGY
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 IN VITRO TOXICITY TESTING MARKET OVERVIEW
3.1 MARKET TRENDS AND FUTURE OUTLOOK
3.2 GLOBAL IN VITRO TOXICITY TESTING MARKET SIZE, 2011 – 2018 (USD MILLION)
3.3 MARKET DYNAMICS
3.3.1 DRIVERS
3.3.1.1 Opposition to Animal Testing
3.3.1.2 Advancement in Toxicity Testing Procedure
3.3.1.3 Strict Regulations from the Government of Different Countries
3.3.2 RESTRAINTS
3.3.2.1 Questionable Predictive Power
3.3.3 OPPORTUNITIES
3.3.3.1 Future Technological and Scientific Innovations
CHAPTER 4 MARKET SEGMENTATION
4.1 IN VITRO TESTING MARKET BY END USE
4.1.1 COSMETICS AND HOUSEHOLD PRODUCTS
4.1.2 PHARMACEUTICAL INDUSTRY
4.1.3 FOOD INDUSTRY
4.1.4 CHEMICALS INDUSTRY
4.2 IN VITRO MARKET SEGMENTATION BY APPLICATION
4.2.1 IN VITRO TOXICITY TESTING METHODS
4.2.2 CYTOTOXICITY ESSAYS USED FOR IN VITRO TOXICITY TESTING
4.3 IN VITRO TOXICITY TESTING MARKET SEGMENTATION BY TYPE
4.3.1 BY ABSORPTION
4.3.1.1 Distribution
4.3.1.2 Metabolism
4.3.1.3 Excretion
4.3.2 BY DOSE
4.3.2.1 Dose Response
4.3.2.2 Threshold Response
4.3.3 BY TOXIC SUBSTANCES
4.3.3.1 Toxicant
4.3.3.2 Toxin
4.3.3.3 Acute and Chronic Toxicity
4.3.3.4 Toxicokinetics
4.4 MARKET SEGMENTATION BY GEOGRAPHY
4.4.1 NORTH AMERICA
4.4.2 EUROPE
4.4.2.1 SWITZERLAND
4.4.3 ASIA
4.4.4 REST OF THE WORLD
CHAPTER 5 COMPETITIVE LANDSCAPE
5.1 MARKET SHARE BY KEY PLAYERS
CHAPTER 6 RECOMMENDATIONS
6.1 MARKET STRATEGY FOR SUCCESS
6.2 BARRIERS TO BE CONSIDERED
CHAPTER 7 COMPANY PROFILES
7.1 BIO-RAD LABORATORIES
7.1.1 COMPANY OVERVIEW
7.1.2 FINANCIAL PERFORMANCE
7.1.3 PRODUCT PORTFOLIO
7.1.4 BUSINESS STRATEGIES
7.1.5 RECENT DEVELOPMENTS
7.2 CYPROTEX
7.2.1 COMPANY OVERVIEW
7.2.2 BUSINESS OVERVIEW
7.2.3 FINANCIAL OVERVIEW
7.2.4 RECENT DEVELOPMENTS
7.3 ACCELRYS INC
7.3.1 COMPANY OVERVIEW
7.3.2 BUSINESS OVERVIEW
7.3.3 FINANCIAL OVERVIEW
7.3.4 RECENT DEVELOPMENTS
7.4 CHARLES RIVER LABORATORIES INTERNATIONAL INC.
7.4.1 COMPANY OVERVIEW
7.4.2 FINANCIAL OVERVIEW
7.4.3 PRODUCT PORTFOLIO
7.4.4 BUSINESS OVERVIEW
7.4.5 RECENT DEVELOPMENTS
7.5 COVANCE INC.
7.5.1 COMPANY OVERVIEW
7.5.2 FINANCIAL OVERVIEW
7.5.3 BUSINESS STRATEGIES
7.5.4 RECENT DEVELOPMENTS
LIST OF TABLES
TABLE 1 DRIVERS OF GLOBAL IN VITRO TOXICITY TESTING MARKET: IMPACT ANALYSIS
TABLE 2 RESTRAINTS FOR IN VITRO TOXICITY TESTING MARKET: IMPACT ANALYSIS
TABLE 3 GLOBAL IN VITRO TESTING MARKET BY END USE, 2012 – 2018 (USD MILLION)
TABLE 4 GLOBAL IN VITRO TOXICITY TESTING MARKET BY TYPE, 2012 – 2018 (USD MILLION)
TABLE 5 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET BY GEOGRAPHY, 2010-2018, (USD MILLION)
TABLE 6 GLOBAL IVTT COSMETICS AND HOUSEHOLD PRODUCTS BY GEOGRAPHY, 2010-2018, (USD MILLION)
TABLE 7 GLOBAL IVTT PHARMACEUTICAL INDUSTRY MARKET BY GEOGRAPHY, 2010-2018, (USD MILLION)
TABLE 8 GLOBAL IVTT FOOD INDUSTRY MARKET BY GEOGRAPHY, 2010-2018, (USD MILLION)
TABLE 9 GLOBAL IVTT CHEMICALS INDUSTRY MARKET BY GEOGRAPHY, 2010-2018, (USD MILLION)
TABLE 10 NORTH AMERICA IVTT MARKET, BY END USE, 2010-2018, (USD MILLION)
TABLE 11 NORTH AMERICA IVTT MARKET, BY TYPES, 2010-2018, (USD MILLION)
TABLE 12 EUROPE IVTT MARKET, BY END USE, 2010-2018, (USD MILLION)
TABLE 13 EUROPE IVTT MARKET, BY TYPES, 2010-2018, (USD MILLION)
TABLE 14 SWITZERLAND IVTT MARKET, BY END USE, 2010-2018, (USD MILLION)
TABLE 15 SWITZERLAND IVTT MARKET, BY TYPE, 2010-2018, (USD MILLION)
TABLE 16 ASIA IVTT MARKET, BY END USE, 2010-2018, (USD MILLION)
TABLE 17 ASIA IVTT MARKET, BY TYPES, 2010 – 2018 (USD MILLION)
TABLE 18 ROW IVTT MARKET, BY END USE, 2010-2018, (USD MILLION)
TABLE 19 ROW IVTT MARKET, BY TYPES, 2010-2018, (USD MILLION)
TABLE 20 MARKET POSITIONING OF MAJOR IN VITRO TOXICITY TESTING MARKET PLAYERS, BY COUNTRY
LIST OF FIGURES
FIG. 1 IN VITRO TOXICITY TESTING MARKET ESTIMATES AND FORECAST, 2012 – 2018 (USD MILLION)
FIG. 2 IN VITRO TOXICITY TESTING MARKET BUBBLE CHART GEOGRAPHY RANKING, 2011 (USD MILLION)
FIG. 3 IN VITRO TOXICITY TESTING MARKET BUBBLE CHART GEOGRAPHY RANKING, 2018 (USD MILLION)
FIG. 4 GLOBAL IN VITRO TOXICITY MARKET ESTIMATES AND FORECAST, 2011 – 2018 (USD MILLION)
FIG. 5 GLOBAL IN VITRO TOXICITY MARKET BY END USE ETIMATES AND FORECAST, 2011 – 2018 (USD MILLION)
FIG. 6 GLOBAL IN VITRO TOXICITY COSMETICS AND HOUSEHOLD PRODUCTS MARKET ESTIMATES AND FORECAST, 2011 – 2018 (USD MILLION)
FIG. 7 GLOBAL IN VITRO TOXICITY PHARMACEUTICAL PRODUCTS MARKET ESTIMATES AND FORECAST, 2011 – 2018 (USD MILLION)
FIG. 8 GLOBAL IN VITRO TOXICITY FOOD PRODUCTS MARKET ESTIMATES AND FORECAST, 2011 – 2018 (USD MILLION)
FIG. 9 GLOBAL IN VITRO TOXICITY CHEMICALS MARKET ESTIMATES AND FORECAST, 2011 – 2018 (USD MILLION)
FIG. 10 GLOBAL IN VITRO TOXICITY MARKET BY TYPE ESTIMATES AND FORECAST, 2011 – 2018 (USD MILLION)
FIG. 11 GLOBAL IN VITRO TOXICITY MARKET BY ABSORPTION ESTIMATES AND FORECAST, 2011 – 2018 (USD MILLION)
FIG. 12 GLOBAL IN VITRO TOXICITY MARKET BY DOSE ESTIMATES AND FORECAST, 2011 – 2018 (USD MILLION)
FIG. 13 GLOBAL IN VITRO TOXICITY MARKET BY TOXIC SUBSTANCES ETIMATES AND FORECAST, 2011 – 2018 (USD MILLION)
FIG. 14 GLOBAL IN VITRO TOXICITY MARKET BY ABSORPTION ESTIMATES AND FORECAST, BY GEOGRAPHY, 2011 – 2018 (USD MILLION)
FIG. 15 GLOBAL IN VITRO TOXICITY MARKET BY TOXIC SUBSTANCES ESTIMATES AND FORECAST, BY GEOGRAPHY, 2011 – 2018 (USD MILLION)
FIG. 16 GLOBAL IN VITRO TOXICITY MARKET BY DOSE ESTIMATES AND FORECAST, BY GEOGRAPHY, 2011 – 2018 (USD MILLION)
FIG. 17 SWITZERLAND IN VITRO TOXICITY MARKET BY END USE ESTIMATES AND FORECAST, 2011 – 2018 (USD MILLION)
FIG. 18 SWITZERLAND IN VITRO TOXICITY MARKET BY TYPE ESTIMATES AND FORECAST, 2011 – 2018 (USD MILLION)